Top Stories for the Week of July 9th 2007

Friday, July 13, 2007 01:38 PM

Top News

 

Criterium Opens Offices in Russia, Israel

Saratoga Springs, N.Y.-based contract research organization (CRO) Criterium has opened two offices in St. Petersburg, Russia, and Yavne, Israel. Criterium made its announcement recently at the 43rd Drug Information Association (DIA) annual meeting in Atlanta, Georgia. Criterium’s trial management model,
which employs technology flexibility and a centralized workflow process, makes its expansion into various emerging markets in clinical research possible.

Medidata Solutions and SAS Partner to Integrate eClinical Data

New York, N.Y.-based eClinical firm Medidata Solutions signed a major integration partnership with Cary, N.C.-based analytical software provider SAS. The two companies have completed - phase I of - a project to integrate Medidata’s clinical data management platform Rave, with SAS’ Drug Development (SAS DD), the company’s biopharmaceutical metadata analysis software.

Other breaking news...      

Company Profile: An interview with Daniel Spasic, chief executive officer, TFS Trial Form Support International

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs